A review on the role of ncRNAs in the pathogenesis of cholangiocarcinoma

Downregulation of tumor-derived exosomal activation to promote 21 (1) (2021), 373-373. Zhang, M. Jiang, D. Kuang, MicroRNA-growth and mediates Galangin's anti-4710-4721. let-7a exert synergistic inhibition cholangiocarcinoma cells through down -(2021), 161-161. Ferreira, M.C.J. Calastri, G.D. Tenani, Costa, M.F.Chaim Correia, E. Alves Da Silva, R.Ferreira Da Silva, A. Tralha similar to o, D.R.S. Souza, cholangiocarcinoma, Asian Pac. Y.-J. Gong, H.-Y. Li, S. Zuo, miR-by relieving DNMT3B-mediated (2021) 6055-6065. Zhang, X. Chen, H. Zhu, L. Chu, miR-cholangiocarcinoma cells through Oncol. 10 (2021), 563486-563486. of microRNA-874 represses NF-kappa B pathway via CCNE1 in 109927. miR-885-5p inhibits proliferation GALNT3 in human intrahepatic (2020) 1371-1381. Zhou, Y. Song, G. Kong, B. Zhang, MicroRNA-129-2-3p directly targets Wip1 to intrahepatic cholangiocarcinoma, Shi, R. Huang, C. Peng, Z.L. He, autophagy and further promotes targeting ULK1, Kaohsiung J. Med. Sci. cholangiocarcinoma cell invasion and migration via inhibiting epithelial-mesenchymal transition, Oncotarget 9 (23) (2018) 16400-16417. [154] J. Ma, L. Weng, Z. Wang, Y. Jia, B. Liu, S. Wu, Y. Cao, X. Sun, X. Yin, M. Shang, A. Mao, MiR-124 induces autophagy-related cell death in cholangiocarcinoma cells through direct targeting of the EZH2-STAT3 signaling axis, Exp. Cell Res. 366 (2) (2018) 103-113. [155] A.P. Mansini, M.J.Lorenzo Pisarello, K.M. Thelen, M. Cruz-Reyes, E. Peixoto, S. Jin, B.N. Howard, C.E. Trussoni, G.B. Gajdos, N.F. LaRusso, M.J. Perugorria, J. M. Banales, S.A. Gradilone, MicroRNA (miR)-433 and miR-22 dysregulations induce histone-deacetylase-6 overexpression and ciliary loss in cholangiocarcinoma, Hepatology 68 (2) (2018) 561-573 (Baltimore, Md.). [156] F. Fan, J. Lu, W. Yu, Y. Zhang, S. Xu, L. Pang, B. Zhu, MicroRNA-26b-5p regulates cell proliferation, invasion and metastasis in human intrahepatic cholangiocarcinoma by targeting S100A7, Oncol. Lett. 15 (1) (2018) 386-392. [157] Y.F. Wu, Z.R. Li, Z.Q. Cheng, X.M. Yin, J.S. Wu, Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc, Biomed. Pharmacother. 96 (2017) 7-13. [158] S. Han, D. Wang, G. Tang, X. Yang, C. Jiao, R. Yang, Y. Zhang, L. Huo, Z. Shao, Z. Lu, J. Zhang, X. Li, Suppression of miR-16 promotes tumor growth and metastasis through reversely regulating YAP1 in human cholangiocarcinoma, Oncotarget 8 (34) (2017) 56635-56650. [159] D. Jiao, Y. Yan, S. Shui, G. Wu, J. Ren, Y. Wang, X. Han, miR-106b regulates the 5-fluorouracil resistance by targeting Zbtb7a in cholangiocarcinoma, Oncotarget 8 (32) (2017) 52913-52922. [160] C. Zu, S. Liu, W. Cao, Z. Liu, H. Qiang, Y. Li, C. Cheng, L. Ji, J. Li, J. Li, MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression, Oncotarget 8 (21) (2017) 34698-34708. [161] F. Tian, J. Chen, S. Zheng, D. Li, X. Zhao, P. Jiang, J. Li, S. Wang, miR-124 targets GATA6 to suppress cholangiocarcinoma cell invasion and metastasis, BMC Cancer 17 (1) (2017), 175-175. [162] P. Wang, L. Lv, miR-26a induced the suppression of tumor growth of cholangiocarcinoma via KRT19 approach, Oncotarget 7 (49) (2016) 81367-81376. [163] C. Wu, J. Zhang, X. Cao, Q. Yang, D. Xia, Effect of Mir-122 on human cholangiocarcinoma proliferation, invasion, and apoptosis through P53 expression, Med. Sci. Monit. 22 (2016) 2685-2690.